Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07371598 · ClinicalTrials.gov registry record · NA
Royal Ancient Oats™ Study
A NA study of Healthy Participants and Healthy Glucose, sponsored by Standard Process.
- Recruiting
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT07371598: Recruiting NA study of Healthy Participants and Healthy Glucose, sponsored by Standard Process.
NCT07371598 is a NA study of Healthy Participants and Healthy Glucose that is actively recruiting participants, run by Standard Process. The registered enrollment target is 38 participants, below the 65-participant average among 119 other Healthy Participants trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07371598, a NA study of Healthy Participants and Healthy Glucose, is actively recruiting participants, sponsored by Standard Process.
- RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluating the effects of high avenanthramide ancient oat (Royal Ancient Oats™) muffins versus conventional oat muffins in regard to glycemic control.
Primary Outcome
Area Under the Curve (AUC) for glucose levels over 24 hours, as measured by Continuous Glucose Monitoring (CGM).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Royal Ancient Oat Flour™
Study Locations (1)
North Carolina
- Standard Process Nutrition Innovation Center - Kannapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2026-01-13 |
| Est. Completion | 2026-09-15 |
| Phase | NA |
What NCT07371598 shows while recruiting
NCT07371598 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 65-participant average among 119 other Healthy Participants trials with a reported enrollment target (42% lower).
The record links to 2 conditions, with Healthy Participants appearing as the primary indexed condition, and to 1 intervention - of which Royal Ancient Oat Flour™ is the first listed.
NCT07371598 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07371598 about?
NCT07371598 is a clinical study titled "Royal Ancient Oats™ Study". Evaluating the effects of high avenanthramide ancient oat (Royal Ancient Oats™) muffins versus conventional oat muffins in regard to glycemic control.
What is the current status of trial NCT07371598?
This trial is currently recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2026-01-13. Estimated completion is 2026-09-15.
What conditions does trial NCT07371598 study?
This clinical trial studies the following conditions: Healthy Participants, Healthy Glucose.
What interventions are being tested in trial NCT07371598?
The interventions under investigation include: Royal Ancient Oat Flour™ (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07371598?
This trial is sponsored by Standard Process, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07371598 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07371598's enrollment target sits among peer trials
38 64th of 119 higher than 55 of 119 other Healthy Participants trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Participants trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Fructose Intestinal Gluconeogenesis
RECRUITING · NA
-
The Increasing Mindfulness Engagement Project
RECRUITING · NA
-
Testing a Non-Invasive Spinal Stimulation Device
RECRUITING · NA
-
Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic Breakfasts.
RECRUITING · NA
-
Effect of Limosilactobacillus Reuteri DSM 17648 in Healthy Adults Reporting Upper Gastrointestinal Discomfort
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI